NNAT and prostate carcinoma: Our finding is consistent with a recent study where NNAT was identified as a target of miR-708-5p in breast cancer.10 By establishing a dual-luciferase reporter vector, we found that miR-708-5p directly inhibits NNAT expression by targeting the 3′-UTR of NNAT mRNA in prostate cancer cells.